Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2000

View Archived Issues

SciClone's Zadaxin prevents lung tumors in mouse model

Trial set to test efficacy of bismuth-213-labeled monoclonal antibody in leukemia patients

Peptide Therapeutics awarded SBIR grant for West Nile vaccine

FDA grants orphan drug status to ALX-0600 as treatment of short bowel syndrome

Siga awarded two SBIR grants to support antibiotic development

D-Pharm's DP-b99 successfully completes phase I study as treatment of acute stroke

Anticonvulsants found to lower efficacy of leukemia chemotherapy

Levetiracetam shows promise as adjunctive therapy for partial onset seizures

Gene therapy boosts hemoglobin production in thalassemic mice

Dalteparin reduces risk of clotting after hip replacement surgery

Gene variant associated with less risk of renal impairment following heart surgery

European Commission approves Myocet as treatment of metastatic breast cancer

Allos Therapeutics completes patient enrollment for RSR-13 trial in lung cancer

Moraxen approved in U.K. for severe cancer pain

Texas Biotechnology announces initial financing of Revotar subsidiary

Lexicon Genetics and Arena to develop GPCR modulators

Foscan PDT shows promise as treatment for head and neck cancer

Aastrom Biosciences receives phase II SBIR award for UCB expansion system

New integrin antagonists in development at Bayer

Boehringer Ingelheim claims new antithrombotic compounds

Cyclin-dependent kinase inhibitors under study at Roche

Mitsubishi Chemical patents amide derivatives active against H. pylori

Compounds with cholesterol biosynthesis-inhibitory activity claimed by Hanwha

New sPLA2 inhibitors under development at Lilly

New compounds with opioid receptor affinity useful for pain treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...